BREAST ATYPICAL LOBULAR HYPERPLASIA
Clinical trials for BREAST ATYPICAL LOBULAR HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL LOBULAR HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL LOBULAR HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer prevention study halted: tamoxifen pill vs. gel tested
Prevention TerminatedThis study aimed to see if a tamoxifen skin gel could work as well as the pill to lower breast cancer risk in women with certain high-risk breast conditions. The trial enrolled 65 women and compared short-term changes in breast tissue. However, the study was terminated early, so …
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Genetic test aims to improve breast cancer decisions for black and hispanic women
Knowledge-focused TerminatedThis study looked at whether adding a polygenic risk score (a genetic test) to standard breast cancer risk tools helps African American and Hispanic women make better decisions about screening and prevention. Researchers enrolled 19 women at higher risk for breast cancer. The stu…
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC